https://www.selleckchem.com/pr....oducts/sndx-5613.htm
DR and true PD were observed in 11 and 51 patients, respectively. The frequency of DR in NSCLC patients who showed PD to anti-PD-1/L1 was 17.7%. Median overall survival was significantly longer in patients with DR versus true PD (14.0 vs. 6.6 months, respectively; hazard ratio for death 0.40; 95% confidence interval 0.17-0.94). CONCLUSIONS Patients with DR exhibited a relatively favorable prognosis.BACKGROUND Employment is recognised as facilitating the personal and clinical recovery of people with psychosocial disability. Yet this gr
Like
Comment
Share
